The Washington Wizards have revealed that forward Cam Whitmore has been diagnosed with deep vein thrombosis (DVT) and will be out indefinitely. Whitmore has missed the last six games, with the most recent two absences linked to soreness in his right shoulder, which was later found to be caused by DVT.
DVT involves blood clots forming in veins, commonly in the arms or legs, and this condition has increasingly affected NBA players. For example, last season Damian Lillard missed time due to a clot in his calf, and Victor Wembanyama’s season was cut short last year after developing a clot in his right shoulder, causing him to miss 29 games.
This diagnosis is a tough setback for Whitmore, who had been averaging 10.4 points on 47% shooting over his last 11 games. The timeline for his return is uncertain, but other players like Wembanyama and Pistons forward Orther Thompson have successfully come back from DVT without complications. Thompson, for instance, missed time over two seasons but is currently performing at a career-high level.
Treatment for DVT varies depending on where the clot is located, but prompt and proper care is crucial since untreated clots can travel to the lungs, leading to a potentially fatal pulmonary embolism.
Given the experiences of other players with DVT, Whitmore might face an extended absence. His situation is challenging, especially as he was traded to the Rockets in the summer and is now in his first season with the Wizards. The team’s wing depth is taking a hit, but with the Wizards holding a league-worst 5-22 record, the priority remains on Whitmore’s long-term health rather than immediate wins.
Fan Take: This diagnosis highlights the importance of health vigilance in professional basketball, reminding fans that player well-being is paramount over short-term success. Whitmore’s journey underscores the resilience of athletes facing serious medical challenges and how advancements in treatment can allow them to return to the game stronger.
